Clinical Trials Logo

Filter by:
NCT ID: NCT02091453 Completed - Stroke Clinical Trials

Early Training of Attention After Acquired Brain Injury

Start date: January 2009
Phase: N/A
Study type: Interventional

Background: To study intensive targeted cognitive rehabilitation of attention in the acute (<4 months) and subacute rehabilitation phases (4 -12 months) after acquired brain injury and to evaluate the effects on function, activity and participation (return to work). Design: prospective, randomised, controlled study. Methods: 120 consecutive patients with stroke or traumatic brain injury are randomised to 20 hours of intensive attention training by Attention Process Training or by standard, activity based training. Progress is evaluated by Statistical Process Control and by pre and post measurement of functional and activity levels. Return to work is also evaluated in the post-acute phase. Primary endpoints are the changes in the attention measure, Paced Auditory Serial Addition Test and changes in work ability. Secondary endpoints include measurement of cognitive functions, activity and work return. There are 3, 6 and 12-month follow ups focussing on health economics. Discussion: The study will provide information on rehabilitation of attention in the early phases after acquired brain injury (ABI); effects on function, activity and return to work. Further, the application of Statistical Process Control might enable closer investigation of the cognitive changes after acquired brain injury and demonstrate the usefulness of process measures in rehabilitation.

NCT ID: NCT02090244 Completed - Spinal Stenosis Clinical Trials

Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?

Start date: August 2012
Phase: Phase 4
Study type: Interventional

Parathyroid (PTH) hormone has been shown to enhance fracture healing in animal studies. There are so far only three published papers concerning humans. Postero-lateral fusions have shown a healing rate of less than 50% after bone. The purpose of this study is to determine if PTH 1-34 (teriparatide) improves the healing rate and the clinical course after spinal stenosis surgery.

NCT ID: NCT02089438 Completed - Type 2 Diabetes Clinical Trials

DPP-4 Inhibition, Incretins and Islet Function

CODI24
Start date: May 2014
Phase: Phase 4
Study type: Interventional

Hypothesis is that DPP-4 inhibition affects glucose levels through changes in incretin and islet hormones. The study examines this in relation to breakfast, lunch and dinner over an entire 24h study period by the use of three different DPP-4 inhibitors and placebo.

NCT ID: NCT02088853 Completed - Healthy Conditions Clinical Trials

Diet Induced Intestinal Mucosal Adaptation

Start date: March 2014
Phase: N/A
Study type: Interventional

Human beings are 'omnivores' meaning that all principal components of food (i.e. the macronutrients: carbohydrates, fat, proteins) can be assimilated by the gastrointestinal tract. When the gut mucosa is exposed to dietary changes it adjusts its functional behaviour. For example, a fatty diet demands certain digestive mechanisms, whereas others are needed to take care of a carbohydrate rich diet. Such dietary induced changes in appearance and functionality of the small intestinal mucosa have been described in animals but only little is known about it in man. The present project aims at elucidating in man if a 2 weeks diet dominated by either fat or carbohydrates, but with similar energy content, is associated with changes in the small intestinal mucosal appearance and metabolic signalling capacity.

NCT ID: NCT02087020 Completed - Clinical trials for Direct Infection of Hip- and Knee Arthroplasty

Debridement, Antibiotics and Implant Retention in Early Periprosthetic Joint Infection: A Retrospective Cohort Study

DAIR
Start date: January 2013
Phase: N/A
Study type: Observational

Introduction: Periprosthetic joint infection (PJI) is a common cause for reoperation after knee and hip arthroplasty surgery. Debridement, antibiotics and implant retention (DAIR) is recommended in early infections (< 4 weeks) and stable implants. Aims: To define the success rate of DAIR in early infections and to identify predictors for success. Material and methods: In a retrospective cohort study we included patients with hip- or knee arthroplasties reoperated for an early PJI at Danderyd Hospital 2007-2012. Logistic regression analysis was used to identify risk factors affecting success rate. Primary outcome variable was the success of the DAIR treatment. Secondary outcome variable vas risk factors for treatment failure.

NCT ID: NCT02086669 Completed - Achalasia Clinical Trials

Pneumatic Dilatation or Surgical Myotomy for Achalasia

Start date: January 2000
Phase: Phase 2
Study type: Interventional

Patients with newly diagnosed achalasia have been submitted to either treatment with pneumatic dilatation or surgical myotomy. Minimal follow up five years.

NCT ID: NCT02084888 Completed - Clinical trials for Coronary Artery Disease

Prognostic Impact of Chronic Total Occlusions

Start date: January 2005
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine the prognostic impact of the presence of chronic total occlusions (CTO) of the coronary arteries in patients undergoing coronary angiography and PCI.

NCT ID: NCT02083991 Completed - Diabetes Mellitus Clinical Trials

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

SAILOR
Start date: January 2013
Phase: Phase 4
Study type: Interventional

Balancing immunosuppressive treatment in organ transplantation in order to achieve effective prevention of rejection on one side and avoidance of negative side effects on the other side is a major challenge, leading to developing different immunosuppressive protocols. Cornerstones of immunosuppressive treatment such as Corticosteroids (CS) and Calcineurin Inhibitors (CNI) are known to cause an increased incidence of diabetes, cardiovascular morbidity, nephrotoxicity and malignancies. The investigators believe that both avoidance of CS and minimization of CNI, while using Anti-ThymocyteGlobuline(ATG) induction (instead of interleucin-2 receptor blockers) and mycofenolate mofetil(MMF) therapeutic drug monitoring is going to reduce negative side effects, without increased rejection frequency in renal transplanted patients.

NCT ID: NCT02083263 Completed - Cystic Fibrosis Clinical Trials

Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis

Start date: October 2012
Phase: N/A
Study type: Interventional

With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).

NCT ID: NCT02079298 Completed - Clinical trials for Bacterial Infections and Mycoses

Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants

Start date: April 2014
Phase: Phase 4
Study type: Interventional

This study will investigate pharmacological interventions between fluconazole and ibuprofen when they are given to premature newborn babys. This in order to find out if the drugs are influencing each other when they are given at the same time. The study is meant to find out if there are reasons to adjust the dose when fluconazole and ibuprofen are given together.